ADM Korea Inc.
Hyundai ADM Bio Inc., a contract research organization, provides clinical services in Asia. It offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. The company also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggrega… Read more
ADM Korea Inc. (187660) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.059x
Based on the latest financial reports, ADM Korea Inc. (187660) has a cash flow conversion efficiency ratio of -0.059x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.27 Billion) by net assets (₩21.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ADM Korea Inc. - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how ADM Korea Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ADM Korea Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ADM Korea Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vulcabras Azaleia S.A
SA:VULC3
|
0.052x |
|
California BanCorp
F:KZ9
|
0.028x |
|
Xiamen International Airport Co Ltd
SHG:600897
|
0.043x |
|
Guotai Epoint Software Co Ltd
SHG:688232
|
0.017x |
|
Ascencio SCA
LSE:0P2J
|
0.050x |
|
Anhui ANLI Artificial Leather
SHE:300218
|
0.037x |
|
i3system Inc
KQ:214430
|
0.073x |
|
Shanghai Ailu Package Co. Ltd.
SHE:301062
|
N/A |
Annual Cash Flow Conversion Efficiency for ADM Korea Inc. (2018–2025)
The table below shows the annual cash flow conversion efficiency of ADM Korea Inc. from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩21.53 Billion | ₩-4.47 Billion | -0.208x | +90.08% |
| 2024-12-31 | ₩6.82 Billion | ₩-14.29 Billion | -2.095x | -1746.73% |
| 2023-12-31 | ₩27.13 Billion | ₩-3.08 Billion | -0.113x | -480.86% |
| 2022-12-31 | ₩30.34 Billion | ₩903.74 Million | 0.030x | +35.52% |
| 2021-12-31 | ₩33.59 Billion | ₩738.21 Million | 0.022x | -94.08% |
| 2020-12-31 | ₩14.34 Billion | ₩5.32 Billion | 0.371x | +219.05% |
| 2019-12-31 | ₩10.89 Billion | ₩1.27 Billion | 0.116x | -23.79% |
| 2018-12-31 | ₩3.81 Billion | ₩581.00 Million | 0.153x | -- |